tiprankstipranks
Trending News
More News >
Regen Biopharma, Inc. (RGBP)
:RGBP
US Market

Regen Biopharma (RGBP) Financial Statements

Compare
120 Followers

Regen Biopharma Financial Overview

Regen Biopharma's market cap is currently $1.83M. The company's EPS TTM is $-0.088; its P/E ratio is ―; Regen Biopharma is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Sep 23Sep 22Sep 21Sep 20
Income Statement
Total Revenue$ 236.56K$ 236.56K$ 235.52K$ 171.19K$ 110.00K
Gross Profit$ 159.34K$ 236.56K$ 185.52K$ 146.19K$ 110.00K
Operating Income$ -417.00K$ -687.00K$ -340.00K$ -201.00K$ -209.00K
EBITDA$ -418.00K$ 1.22M$ 2.99M$ -6.40M$ 4.36M
Net Income$ -668.00K$ 1.02M$ 2.23M$ -6.76M$ 2.73M
Balance Sheet
Cash & Short-Term Investments$ 716.00$ 121.04K$ 51.20K$ 727.16K$ 0.00
Total Assets$ 177.61K$ 353.62K$ 559.00K$ 1.21M$ 123.19K
Total Debt$ 814.70K$ 756.20K$ 1.27M$ 3.58M$ 2.60M
Net Debt$ 813.98K$ 635.17K$ 1.22M$ 2.86M$ 2.60M
Total Liabilities$ 5.37M$ 5.46M$ 8.60M$ 14.70M$ 7.46M
Stockholders' Equity$ -5.19M$ -5.10M$ -8.04M$ -13.49M$ -7.33M
Cash Flow
Free Cash Flow$ -693.14K$ -173.92K$ -606.92K$ -1.13M$ 18.64K
Operating Cash Flow$ -693.14K$ -173.92K$ -606.92K$ -1.13M$ 18.64K
Investing Cash Flow$ 0.00$ 0.00$ 25.00K$ 495.00K$ 0.00
Financing Cash Flow$ 572.82K$ 243.75K$ -94.04K$ 1.36M$ -26.50K
Currency in USD

Regen Biopharma Earnings and Revenue History

Regen Biopharma Debt to Assets

Regen Biopharma Cash Flow

Regen Biopharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis